Levothyroxine Teva

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Levothyroxine Teva

Quick Facts about Levothyroxine Teva

Property Description
Active ingredient Levothyroxine Sodium (L-thyroxine)
Form Tablet, Oral formulation
Pharmacological class Thyroid preparation, Endocrine agent
Common use Hormone replacement therapy
Origin Synthetic hormone

What Type of Medicine is Levothyroxine Teva?

Levothyroxine Teva is a pharmaceutical preparation classified as an endocrine agent and a thyroid preparation, used for hormone replacement therapy. This product is a prescription-only medicine containing the active substance Levothyroxine Sodium (L-thyroxine), which is the primary form of thyroid hormone produced by the body. Levothyroxine is recognized for its therapeutic importance globally. L-thyroxine replacement is a standard clinical practice, and the drug belongs to the H03AA therapeutic group.


Levothyroxine: Synthetic Hormone and Tablet Form

The active ingredient, Levothyroxine Sodium, is a synthetic hormone, meaning it is a man-made, chemically precise copy of the natural thyroxine (T4). This synthetic equivalent is structurally identical to the hormone produced by the human thyroid gland. The product is manufactured as an oral formulation in the form of a tablet, a convenient single-ingredient product designed to be taken by mouth and absorbed into the systemic circulation. This synthetic origin is a differentiating factor, as it ensures highly uniform and consistent drug content, eliminating the variability associated with older preparations derived from animal thyroid tissue.


What is the General Purpose of Thyroid Replacement Therapy?

The general purpose of this therapy is metabolic replacement, which involves supplying the necessary T4 hormone to maintain normal biological functions. Levothyroxine works by engaging in hormone replication, helping to restore the body’s essential hormonal balance when native production is insufficient. A typical use scenario involves regulating a patient's thyroid hormone levels back to a healthy range. By supplying this crucial substance, the medicine supports essential metabolic processes throughout the body, including those governing energy production, protein synthesis, and regulation of growth, thus maintaining overall systemic biological equilibrium.

Regulatory References

  1. WHO Essential Medicines List - Levothyroxine

What side effects are possible with Levothyroxine Teva?

Possible Side Effects and Safety Information

The safety profile of levothyroxine is characterized primarily by adverse reactions that are manifestations of therapeutic overdosage, meaning they resemble symptoms of excessive thyroid hormone (hyperthyroidism). These effects are typically observed when the dose exceeds the patient's individual requirement for hormone replacement.


Adverse Reaction Categories and Frequency

Many common reactions, such as tachycardia (increased heart rate), palpitations, tremor, headache, insomnia, and flushing, are associated with overtreatment. In certain official labeling, the frequency of these effects is classified as Not Known because they relate to dose excess, rather than the drug's inherent toxicity at the correct replacement dose.

The officially documented adverse effects impact several System-Organ Classes, including Cardiac disorders (e.g., arrhythmia), Nervous system disorders (e.g., headache, tremor), Psychiatric disorders (e.g., restlessness), and Skin and subcutaneous tissue disorders (e.g., alopecia, excessive sweating).


Serious Safety Considerations

Serious adverse reactions, often linked to over-replacement, include major cardiac events such as myocardial infarction, cardiac arrest, and severe atrial fibrillation, particularly in older patients with pre-existing heart conditions. A life-threatening endocrine event, Thyrotoxic Crisis, is also documented. In rare instances, seizures have been reported, sometimes associated with the initiation of therapy.

Population-Specific Safety Notes

The regulatory label includes specific cautions for certain groups. For elderly patients, careful dose titration is essential due to the heightened risk of cardiac adverse reactions. Postmenopausal women on long-term treatment with doses higher than required for replacement face an increased risk of decreased bone mineral density.


Safety Restrictions and Prohibitions

The medicine is officially contraindicated and must not be used in individuals with untreated hyperthyroidism, acute myocardial infarction, acute myocarditis, or untreated adrenal insufficiency. Furthermore, regulatory agencies specify that levothyroxine should not be used for weight loss or obesity treatment in patients who have normal thyroid function.

Overdose and Emergency Response

Overdose and when to seek help

Overdose with Levothyroxine Teva is officially documented as potentially leading to symptoms consistent with acute thyrotoxicosis or hyperthyroidism. The clinical manifestations may be delayed for several days following an acute massive ingestion. Documented symptoms often affect the cardiovascular and nervous systems, including palpitations, tachycardia, tremor, nervousness, and insomnia, along with general signs like fever (pyrexia) and weight loss.

Regulators state that overdose carries a risk of serious, life-threatening, or fatal outcomes. Severe complications include myocardial infarction, cardiac arrest, and the onset of a thyrotoxic crisis. Elderly patients and individuals with underlying cardiovascular disease are explicitly noted to be at an increased risk of these severe cardiac adverse reactions.

Due to the severity of documented risks, it is explicitly required to seek immediate medical attention or contact emergency services if an overdose is suspected or if severe symptoms occur. Treatment is solely symptomatic and supportive, as no specific antidote is known for Levothyroxine Sodium. Management procedures described in official labeling may include activated charcoal to reduce absorption and cardiac monitoring to observe for cardiovascular effects.

Therapeutic Uses of Levothyroxine Teva

Quick Facts

  • Primary Use: Management of underactive thyroid function (hypothyroidism).
  • Additional Uses: Supportive measure for specific types of thyroid cancer following surgery, prevention of goiter recurrence after surgical treatment, and management of benign goiter.
  • Therapeutic Goal: Replaces the thyroid hormone that the body is unable to produce adequately.

Levothyroxine Teva is a medication used to address conditions associated with insufficient thyroid hormone production. The core application is the replacement therapy for all forms of underactive thyroid function, a condition known as hypothyroidism. Its primary function is to normalize the levels of thyroid hormone within the body.

Beyond this primary indication, this medicine is utilized in certain contexts to manage structural changes of the thyroid gland. It is applied for the management of benign goiter (non-malignant enlargement of the thyroid) in individuals who have normal thyroid function. It is also used to help prevent the recurrence of goiters after patients have undergone surgery for their goiter.

A further therapeutic domain is in the management of specific thyroid malignancies. Levothyroxine Teva serves as an adjunct to surgery and radioiodine therapy for thyrotropin-dependent well-differentiated thyroid cancer, where it is used to suppress growth signals that may influence tumor cells.

Eligibility and Restrictions for Use

Who Can and Cannot Use Levothyroxine Teva?

This section outlines the population eligibility and non-eligibility for Levothyroxine Teva based strictly on official regulatory documents.


Absolute Contraindications

Levothyroxine Teva must not be used by patients with the following conditions, as they are considered absolute contraindications:

  • Untreated thyrotoxicosis (overt hyperthyroidism).
  • Uncorrected adrenal insufficiency (or uncorrected hypocortisolism).
  • Acute myocardial infarction, acute myocarditis, or acute pancarditis.
  • Known hypersensitivity to levothyroxine or any of the product’s excipients.

Conditional Use and Restrictions

Use is established and approved for the treatment of hypothyroidism in the general adult and pediatric populations. However, specific patient groups require caution or conditional use:

  • Cardiovascular Conditions: Patients with pre-existing coronary artery disease or hypertension must have their conditions stabilized before treatment begins. Dosage initiation is restricted and requires special clinical monitoring.
  • Older Adults (Geriatric): Use is permitted but often requires a more gradual initiation due to an increased risk of cardiac events.
  • Pregnancy and Lactation: Use is permitted and essential during pregnancy and is generally permitted while breastfeeding.

Note: Levothyroxine Teva is not indicated for the treatment of obesity or for weight loss.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Levothyroxine is subject to significant interactions that primarily affect its absorption and metabolism, necessitating careful monitoring and specific dosing schedules for numerous co-administered products.

Interactions Affecting Levothyroxine Efficacy (Reduced Absorption/Effect):

Interacting Product Category Mechanism / Constraint
Cation-Containing Agents (e.g., antacids, calcium, iron, sucralfate) Reduce absorption by binding levothyroxine in the gut; must be taken at least 4 hours apart from Levothyroxine Teva.
Bile Acid Sequestrants/Resins (e.g., cholestyramine, colestipol) Bind levothyroxine in the gut, reducing absorption; generally, should be separated by 4 to 5 hours.
Proton Pump Inhibitors (PPIs) (e.g., omeprazole, lansoprazole) Reduce gastric acidity required for optimal levothyroxine dissolution and absorption. Thyroid function monitoring and potential dose adjustment are required upon starting or stopping PPI therapy.
Tyrosine-Kinase Inhibitors, Amiodarone, Anti-convulsants (e.g., phenytoin, carbamazepine) May decrease levothyroxine efficacy via altered metabolism or reduced conversion to the active form. Close thyroid function monitoring is mandatory.

Levothyroxine Affecting Other Medicines (Altered Efficacy):

  • Anticoagulants (Coumarin Derivatives): Levothyroxine can enhance the effect of anticoagulants (e.g., warfarin) by displacing them from plasma protein binding. Blood clotting status must be monitored closely, and the anticoagulant dosage may need to be reduced.
  • Anti-diabetic Agents: Levothyroxine can reduce the effect of insulin and oral anti-diabetic medications (e.g., metformin, sulfonylureas). Diabetics require frequent blood sugar monitoring and potential adjustment of their anti-diabetic dose, especially when levothyroxine therapy is initiated or changed.
  • Tricyclic Antidepressants/Sympathomimetics: Levothyroxine increases sensitivity to catecholamines, accelerating the effects of tricyclic antidepressants and enhancing the effects of sympathomimetic agents.

Mechanism of Action

How Levothyroxine Teva Works

Levothyroxine sodium is a synthetic form of the prohormone thyroxine (T4). Following absorption, Levothyroxine is converted primarily in peripheral tissues, such as the liver and kidney, into its biologically active metabolite, triiodothyronine (T3), through the action of deiodinase enzymes. T3 acts as an agonist by diffusing into the cell nucleus and binding with high affinity to specific nuclear thyroid hormone receptors (TRs), which are members of the steroid/thyroid hormone receptor superfamily.

Binding of T3 to TRs induces a conformational change that promotes the dissociation of corepressor proteins and the recruitment of coactivator complexes. This complex formation directly modulates the transcription of specific target genes. These genes encode for proteins crucial for regulating metabolic processes, including energy expenditure, oxygen consumption, and lipid metabolism. The resulting systemic up- or downregulation of gene expression influences basal metabolic rate, cardiac function (chronotropy and inotropy), and cellular differentiation across multiple organ systems. The mechanism is identical to that of endogenous T4.

Dosage and Administration Information

Official Administration Guidelines

Levothyroxine sodium is typically administered via the oral route as a tablet for long-term replacement therapy. The medication is used once daily as a single dose. Administration of the active substance is also utilized for the intravenous route in acute, life-threatening scenarios, such as myxedema coma.

Timing and Preparation

To ensure optimal absorption, the tablet must be taken on an empty stomach, preferably one-half to one hour before breakfast. It is a critical procedural condition that the medicine be administered at least four hours before or after products known to interfere with absorption, including calcium or iron supplements and certain antacids. For infants unable to swallow whole, tablets may be crushed and suspended in a small amount of water for immediate administration; the resulting mixture must not be stored.

Dosage and Adjustment Schedule

Dosage is highly individualized and determined by patient response. A standard full replacement dose for a healthy adult is approximately 1.6 mcg per kilogram of body weight daily. For certain populations, such as older adults or those with pre-existing heart conditions, therapy must be initiated at a lower starting dose, often 12.5 to 25 mcg daily. The dose titration and evaluation tempo requires the healthcare provider to adjust the dose in small increments (12.5 to 25 mcg) at intervals ranging from four to eight weeks, as the full effect of any dose change is not stabilized for four to six weeks. If a dose is missed, it should be taken as soon as remembered, but two doses must not be taken at once.

Recent Clinical Evidence

Levothyroxine Teva: Recent Clinical Evidence

Overview of Monotherapy Research

Levothyroxine, the synthetic version of the thyroid hormone T4, remains the established standard of care for replacing missing hormone in conditions like primary hypothyroidism. Clinical research consistently shows that the treatment is effective at normalizing levels of Thyroid Stimulating Hormone (TSH), which is the key metric for successful thyroid hormone replacement. Studies have evaluated the use of the drug in patients experiencing severe, chronic pain and persistent migraines, aiming to measure changes in symptom intensity and duration as thyroid function is corrected.

Bioequivalence and Formulation

Following earlier regulatory concerns regarding product consistency, the manufacturer undertook significant reformulation and process improvements. Subsequent bioequivalence studies comparing the reformulated Levothyroxine Teva tablets to the reference standard found that the products produced similar levels of thyroid hormone in the bloodstream, reinforcing product consistency. These studies are critical for levothyroxine products, which are often classified as having a narrow therapeutic index, meaning small changes in drug amount can affect patient outcomes. The addition of new low-strength tablets (e.g., 12.5 mcg) was introduced to assist with the precise, individualized dose adjustments required for optimal therapy.

Combination Therapy Findings

While levothyroxine monotherapy (T4 alone) is the standard approach, research continues to explore combination therapy using T4 and T3 (liothyronine) for the approximately 10–15% of patients who report persistent hypothyroid symptoms despite having TSH levels within the target range. Most randomized controlled trials (RCTs) to date have not found consistent evidence of a significant benefit from the combination of T4/T3 over T4 monotherapy in measures of quality of life or neurocognitive function. However, some trials have found that a significant proportion of participants express a preference for the combined regimen. Guidelines support that a supervised trial of T4/T3 may be considered on an individualized basis for symptomatic patients on optimized T4 treatment.

Key Studies & References

  1. Levothyroxine Sodium Tablets (Teva, generic label) - FDA Approved Drug Products and Labeling
  2. NICE Guideline NG145: Thyroid disease: assessment and management

Frequently Asked Questions (FAQ)

Common questions about Levothyroxine Teva (FAQ)

Q: Is Levothyroxine Teva the same as other levothyroxine brands?

A: Levothyroxine Teva contains synthetic levothyroxine sodium (L-T4), which is the active ingredient in all levothyroxine products and is chemically identical to the hormone produced by the human body. Official regulatory processes require all brands to undergo bioequivalence testing to demonstrate they produce similar levels of the thyroid hormone in the bloodstream compared to a reference standard.


Q: How long does it typically take to feel any effects from Levothyroxine Teva?

A: According to official patient information, initial improvement in symptoms is usually gradual. It may take several weeks before a patient begins to notice changes in their symptoms. Full therapeutic effect and stabilization of thyroid hormone levels after a dose adjustment usually takes about four to six weeks.


Q: What should I do if I accidentally miss a dose of Levothyroxine Teva?

A: Regulatory guidance states it should be taken as soon as it is remembered. However, if it is nearly time for your next scheduled dose, the missed dose should be skipped entirely. Official guidance advises that two doses must not be taken at the same time.


Q: Can I crush or split Levothyroxine Teva tablets if I have trouble swallowing them?

A: Official guidance specifically mentions that for infants who cannot swallow the tablet, it may be crushed and suspended in a small amount of water for immediate use. For adults, generally, the tablets are not intended to be cut or crushed. If administration difficulties occur for adults, consultation with a healthcare professional regarding methods is indicated.


Q: Are there any specific safety warnings for older adults using Levothyroxine Teva?

A: Yes, regulatory warnings state that treatment for older adults (geriatric patients) is typically initiated at a lower initial dose. This precaution is necessary because this group has an increased risk of experiencing cardiac side effects, such as atrial fibrillation, if the dose is too high.


Q: How often do I need blood tests while taking Levothyroxine Teva?

A: The effectiveness of therapy is monitored by periodic assessment of laboratory tests (such as TSH and T4 levels). Official guidance generally recommends this monitoring every 6 to 12 months for adult patients who are on a stable, long-term replacement dosage. When a dose change is made, monitoring is more frequent, often required 6 to 8 weeks after the change.


Q: Is weight gain a possible side effect of starting Levothyroxine Teva?

A: Official documentation notes that Levothyroxine Teva is not indicated for use as a weight loss treatment. Weight changes may be a sign that the dosage is not optimal. Side effects associated with taking too much thyroid hormone often include symptoms like weight loss, not weight gain.


Q: Does Levothyroxine Teva interact with birth control pills?

A: Yes, official drug interaction information notes that estrogens, which are found in some oral contraceptives, can increase the body's requirement for thyroid hormone. Official information indicates that monitoring and potential dose adjustments may be required for patients taking estrogens.


Q: Why do official sources sometimes describe side effects as 'rare' or 'uncommon'?

A: Official medical sources use standardized categories to classify the frequency of documented side effects, based on data from clinical studies and post-market reporting. For instance, an effect classified as 'Uncommon' typically means it is expected to occur in less than 1 in 100 patients, ensuring consistent global reporting.


Q: Does Levothyroxine Teva have any known interactions with herbal teas or remedies?

A: The main official interaction lists focus on pharmaceuticals and high-cation supplements. Regulatory documents recommend that all medicines, vitamins, and herbal products being used should be discussed with a healthcare professional, as some substances may require extra monitoring or adjustment of the Levothyroxine Teva dose.


Q: Is it possible to become resistant to Levothyroxine Teva over time?

A: True resistance to the hormone itself is not commonly described in official regulatory information. However, clinical and lab evidence of hypothyroidism can persist if there are issues with poor absorption (e.g., due to interactions), poor adherence, or other factors that prevent the body from receiving and utilizing the correct amount of the hormone.


Q: What is the difference between primary and secondary hypothyroidism in the context of Levothyroxine Teva?

A: Official indications note that Levothyroxine Teva is used to treat both types. Primary hypothyroidism means the thyroid gland itself is failing to produce enough hormone. Secondary (or tertiary) hypothyroidism means the imbalance is caused by a problem with the pituitary gland or hypothalamus, which controls the thyroid.


Q: What are the general expectations for weight changes after starting Levothyroxine Teva?

A: The primary goal of treatment is to restore a normal metabolic rate. For patients who experienced hypothyroid symptoms like weight gain (often due to fluid retention and slow metabolism), successful replacement therapy is generally expected to lead to the stabilization or reduction of that specific hypothyroid-related weight change, but the drug is not for cosmetic weight loss.


Q: What potential interactions are there between Levothyroxine Teva and common blood pressure medicines?

A: Thyroid hormones can increase heart rate and myocardial contractility. Regulatory warnings recommend that therapy for patients with pre-existing heart conditions or hypertension should start cautiously at reduced dosages. While not all blood pressure medicines have direct pharmacokinetic interactions, the condition itself requires careful monitoring when starting treatment.


Q: Why does my doctor emphasize taking Levothyroxine Teva at the same time every day?

A: Regulatory guidance stresses the importance of taking the dose on a consistent, fixed schedule (same time of day and in relation to meals) to help maintain stable hormone blood levels. This consistency is critical for successful therapy, especially since the drug has a narrow therapeutic window, meaning small variations can affect efficacy.


Q: Do children take the same kind of Levothyroxine Teva as adults?

A: The medication contains the same active substance (Levothyroxine Sodium) and is approved for the pediatric population. However, the dosage is based on body weight and specific age-related monitoring protocols are in place to support normal growth and neurological development in children.


Q: What research evidence supports the use of Levothyroxine Teva for thyroid replacement?

A: Levothyroxine is the established standard of care for hormone replacement in hypothyroidism. Its clinical utility is supported by decades of pharmacological study, demonstrating its effectiveness at normalizing TSH levels. The drug's importance is recognized globally, and it is included on the WHO List of Essential Medicines.


Q: Is Levothyroxine Teva a lifelong medication for most people?

A: According to patient information and official classification as a long-term replacement therapy, when Levothyroxine Teva is used to treat chronic conditions like hypothyroidism, treatment is often required for the rest of the patient's life to continuously replace the missing hormone.


Q: Can taking Levothyroxine Teva affect my ability to sleep?

A: Yes, insomnia (trouble sleeping) is an officially documented side effect that has been reported. This effect, along with other symptoms like restlessness or nervousness, is typically a manifestation of therapeutic overdosage (taking too much thyroid hormone).


Q: Is Levothyroxine Teva safe to use during pregnancy?

A: Yes, official regulatory labeling indicates that thyroid hormone replacement is essential during pregnancy and should be continued. Untreated hypothyroidism during pregnancy is associated with a higher rate of complications, and the medication is classified in Pregnancy Category A.


Q: Does Levothyroxine Teva affect cholesterol levels?

A: Levothyroxine plays a role in regulating the body's metabolic processes, which includes lipid metabolism (the breakdown of fats like cholesterol). Untreated hypothyroidism often causes high cholesterol, so successful replacement therapy is expected to help restore normal cholesterol and lipid levels.


Q: Are there any long-term effects of taking Levothyroxine Teva?

A: Official warnings state that long-term use with a dosage higher than required (over-replacement) in postmenopausal women is associated with an increased risk of decreased bone mineral density. Using the lowest effective dose helps mitigate this specific long-term risk.


Q: Can Levothyroxine Teva affect bone density?

A: Yes. When the dose is higher than necessary (over-replacement), it can potentially increase bone resorption and lead to a decrease in bone mineral density. This risk is a specific regulatory concern, particularly for postmenopausal women.


Q: Can Levothyroxine Teva cause anxiety or nervousness?

A: Yes, anxiety, restlessness, and nervousness are documented adverse reactions listed in the official safety information. These effects are often associated with taking a dosage that is too high and are manifestations of therapeutic overdosage.


Q: Can Levothyroxine Teva cause hair loss, and is that permanent?

A: Alopecia (hair loss) is a documented adverse reaction in the official safety information. Clinical reports suggest that any hair loss experienced is often temporary and is linked to the body adjusting to the hormone levels, particularly when first starting the therapy or if the dose is not yet optimized.


Q: Are there specific symptoms that indicate Levothyroxine Teva is starting to work?

A: While the clinical measure of success is the normalization of TSH blood levels, patients often report a gradual reduction in common hypothyroid symptoms. These improvements can include less fatigue and a reduction in symptoms like cold intolerance as hormone levels begin to stabilize, which usually takes several weeks.


Q: Does the time of year or season affect the needed dose of Levothyroxine Teva?

A: Official regulatory information emphasizes that the dose is highly individualized and is based on ongoing clinical and biochemical evaluation. Although seasons are not specifically named, any factor that alters the body's metabolism, such as major changes in patient condition, may require monitoring and potential dose adjustment.


Q: Is it common for the Levothyroxine Teva dose to change after a patient loses or gains a lot of weight?

A: The initial dose is often calculated based on body weight. Regulatory guidance states that significant changes in patient condition, including substantial weight gain or loss, are factors that may require a re-evaluation of the dose and monitoring of thyroid levels to maintain optimal therapy.


Q: What is the difference between Levothyroxine Teva and Armour Thyroid?

A: Levothyroxine Teva is a single-ingredient product containing only synthetic Levothyroxine Sodium (T4). Armour Thyroid is a brand name for a desiccated thyroid extract (DTE) derived from animal glands, which contains a combination of both T4 and T3 hormones. They are both replacement therapies, but their hormonal composition differs.


Q: What is meant by the term 'therapeutic window' when talking about Levothyroxine Teva?

A: The therapeutic window refers to the concentration range of the medicine in the body that produces the desired effects without causing unacceptable toxicity. For this medicine, it refers to the narrow range of TSH and T4 levels that must be maintained to achieve euthyroidism (normal thyroid function) while preventing the symptoms of under- or over-replacement.


Q: Is it common to have to adjust the dose of Levothyroxine Teva over time?

A: Yes. The initial dosage is only a starting point, and the dose is highly individualized. Official documents indicate that ongoing dose adjustment is often necessary throughout a patient’s life based on continuous TSH level monitoring and clinical evaluation. Factors such as aging, pregnancy, and changes to other medications can all necessitate a dose adjustment.

How should Levothyroxine Teva be stored and disposed of?

How to Store and Dispose of Levothyroxine Teva Tablets

Storage and disposal must strictly adhere to regulatory requirements to maintain drug stability and ensure proper handling.


Official Storage Conditions

Requirement Official Regulatory Mandate
Temperature Store below 25°C (77°F).
Protection Must be protected from light and moisture to prevent degradation.
Container Keep the medicine in the original container and keep it tightly closed.
Child Safety Must be kept out of the sight and reach of children.

Disposal Instructions

Disposal of unused or expired Levothyroxine Teva must be carried out in accordance with local pharmaceutical waste requirements. Do not dispose of the medicine by pouring it down a sink or toilet, which is an environmental restriction advised by health authorities for many medications.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Levothyroxine Teva found in:

A-Z Index: